

Lipopeptide Peptide (200mg) | Elite Peptide
Original price was: £200.00.£99.00Current price is: £99.00.
Order Lipopeptide peptide (200mg) with >99% purity. Research peptide Pal-GQPR studied for potential skin penetration and immune-related functions.
Description
What is Lipopeptide Peptide?
Lipopeptide 200mg peptide is a synthetic tetrapeptide characterized by the sequence Palmitoyl-Gly-Gln-Pro-Arg (Pal-GQPR). It is derived from a fragment of immunoglobulin G (IgG), an antibody that plays a critical role in the immune system. Researchers modified this peptide by attaching a palmitic acid molecule, a process known as palmitoylation. This modification appears to improve the peptide’s stability and enhance its ability to interact with biological systems.
Research Focus
Scientific studies suggest that palmitoylation increases the peptide’s ability to penetrate skin tissue models, particularly through the lipid-rich corneal layers. This enhanced penetration may allow the peptide to reach deeper tissues, making it of interest in research on skin health, inflammation, and cellular repair.
Biological Significance
Immunoglobulin fragments are often studied for their role in regulating inflammatory pathways. By modifying such fragments into a lipopeptide form, scientists aim to better understand their potential in modulating immune system responses. Preliminary research indicates that lipopeptides may support tissue recovery processes and help regulate inflammation at the cellular level.
Supporting Studies
Although research is ongoing, early experimental findings highlight the potential of Lipopeptide peptide as a bioregulator with enhanced skin penetration. These studies propose that the lipid modification may increase its biological availability and possibly improve experimental outcomes in cellular models.
Chemical Makeup
-
Molecular Formula: C38H68N6O8
-
Molecular Weight: 736.9 g/mol
-
Sequence: Pal-Gly-Gln-Pro-Arg
-
Other Names: Pal-GQPR, Palmitoyl Tetrapeptide-7, Palmitoyl Tetrapeptide-3
Reviews
There are no reviews yet.